Fundraising Fox

Herman Verrelst

Investor

Founding Partner & Senior Advisor at Heran Partners

Leuven, Flemish Region, Belgium

About

Herman Verrelst is a serial entrepreneur with over 25 years in high-tech companies. He founded and exited several University of Leuven spin-offs, including Cartagenia, which was acquired by Agilent, after which he led Agilent's Genomics & Clinical Applications division in California. He later served as CEO of Biocartis, a molecular diagnostics company focused on personalized medicine.

ContactΒ· self-published, not guessed

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Experience

  1. GynaiaExecutive Chairmancurrent2025 β€” present
  2. Aspect AnalyticsChairpersoncurrent2025 β€” present
  3. Aspect AnalyticsBoard Member2025
  4. Aspect AnalyticsExecutive Chair2023 β€” 2024
  5. nuclivisionBoard Membercurrent2025 β€” present
  6. HERAN PartnersFounding Partnercurrent2020 β€” present
  7. BioviaBoard Membercurrent2025 β€” present
  8. BiocartisChairman2023 β€” 2025
  9. BiocartisExecutive Chairman2023
  10. BiocartisChief Executive Officer2017 β€” 2023
  11. MedviaChairman of the Board2021 β€” 2025
  12. Ellison Institute of Technology OxfordChief Business Officer2024Oxford, England, United Kingdom
  13. icoMetrixBoard Member2013 β€” 2024
  14. flanders.bioBoard Member2018 β€” 2022
  15. FOx BiosystemsBoard Member2019 β€” 2020
  16. UgenTecBoard Member2015 β€” 2018
  17. Agilent TechnologiesVP and General Manager - Genomics and Clinical Application division2015 β€” 2017Santa Clara, California
  18. Agilent TechnologiesGeneral Manager - Clinical Applications Division2015
  19. CartageniaChief Executive Officer2011 β€” 2015
  20. CartageniaManaging Director2008 β€” 2011
  21. ParticipatieMaatschappij VlaanderenMember Investment Committee - VINNOF2010 β€” 2015
  22. EpsynomicsManaging Director2009 β€” 2010
  23. Nobel BiocareBusiness Unit Manager2008 β€” 2009
  24. Medicim NVManaging Director2007 β€” 2009
  25. Norkom TechnologiesDirector European Operations2004 β€” 2007
  26. DATA4sCEO2000 β€” 2004
  27. Katholieke Universiteit LeuvenPhD Researcher1996 β€” 1999

Skills & more

Start-ups40Lifesciences11Entrepreneurship26Biotechnology12Business Development6Business Strategy17Venture Capital7Due Diligence2Healthcare2Data Analysis1Mergers & Acquisitions3Private Equity3
+5 moreMolecular BiologyLife SciencesAnalysisManagementStrategy

From Herman's professional profile.

Colleagues at Heran Partners

Frequently asked questions

Who is Herman Verrelst?
Herman Verrelst is a serial entrepreneur with over 25 years in high-tech companies. He founded and exited several University of Leuven spin-offs, including Cartagenia, which was acquired by Agilent, after which he led Agilent's Genomics & Clinical Applications division in California. He later served as CEO of Biocartis, a molecular diagnostics company focused on personalized medicine.
Where does Herman Verrelst work?
Herman Verrelst is Founding Partner & Senior Advisor at Heran Partners.
What does Herman Verrelst invest in?
Herman Verrelst invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
Where did Herman Verrelst go to school?
Herman Verrelst studied at KU Leuven (Master in Engineering); Stanford University Graduate School of Business (Leading Change and Organizational Renewal).

Founder mafias

Same school

Shared employers